A phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors.
Jean-Charles Soria
No relevant relationships to disclose
Filippo G. De Braud
Consultant or Advisory Role - EOS GmbH; Novartis; Roche; SERVIER
Research Funding - Novartis; SERVIER
Ratislav Bahleda
No relevant relationships to disclose
Barbara Adamo
No relevant relationships to disclose
Roberta Cereda
Employment or Leadership Position - EOS S.p.A.
Maria Gabriella Camboni
Employment or Leadership Position - EOS S.p.A.
Stock Ownership - Clovis
Renata Robert
Employment or Leadership Position - Iris
Jeffrey D. Isaacson
Employment or Leadership Position - Clovis
Stock Ownership - Clovis
Jason B. Litten
Employment or Leadership Position - Clovis
Stock Ownership - Amgen; Clovis
Andrew R. Allen
Employment or Leadership Position - Clovis
Stock Ownership - Clovis
Lindsey Rolfe
Employment or Leadership Position - Clovis
Stock Ownership - Clovis
Josep Tabernero
Consultant or Advisory Role - Amgen; Celgene; Chugai Pharma; ImClone Systems; Lilly; Merck KGaA; Millennium; Novartis; Roche; Sanofi ; Taiho Pharmaceutical
Honoraria - Amgen; Merck KGaA; Novartis; Roche; Sanofi